AU2010238409A1 - Derivatives of N-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, preparation thereof, and therapeutic use thereof - Google Patents
Derivatives of N-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, preparation thereof, and therapeutic use thereof Download PDFInfo
- Publication number
- AU2010238409A1 AU2010238409A1 AU2010238409A AU2010238409A AU2010238409A1 AU 2010238409 A1 AU2010238409 A1 AU 2010238409A1 AU 2010238409 A AU2010238409 A AU 2010238409A AU 2010238409 A AU2010238409 A AU 2010238409A AU 2010238409 A1 AU2010238409 A1 AU 2010238409A1
- Authority
- AU
- Australia
- Prior art keywords
- alkyl
- compound
- disorders
- treatment
- hept
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/14—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0901809A FR2944284A1 (fr) | 2009-04-14 | 2009-04-14 | Derives de n-°7-aza-bicyclo°2.2.1!hept-1-yl)-aryl-methyl! -benzamide, leur preparation et leur application en therapeutique |
FR09/01809 | 2009-04-14 | ||
PCT/FR2010/050711 WO2010119222A1 (fr) | 2009-04-14 | 2010-04-13 | Derives de n-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, leur preparation et leur application en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2010238409A1 true AU2010238409A1 (en) | 2011-11-03 |
Family
ID=41228015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2010238409A Abandoned AU2010238409A1 (en) | 2009-04-14 | 2010-04-13 | Derivatives of N-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, preparation thereof, and therapeutic use thereof |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP2419431A1 (es) |
JP (1) | JP2012523448A (es) |
KR (1) | KR20120013378A (es) |
AR (1) | AR076276A1 (es) |
AU (1) | AU2010238409A1 (es) |
BR (1) | BRPI1015484A2 (es) |
CA (1) | CA2758367A1 (es) |
FR (1) | FR2944284A1 (es) |
IL (1) | IL215673A0 (es) |
MX (1) | MX2011010929A (es) |
SG (1) | SG175222A1 (es) |
TW (1) | TW201041581A (es) |
UY (1) | UY32561A (es) |
WO (1) | WO2010119222A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20160045182A (ko) | 2014-10-16 | 2016-04-27 | 현대자동차주식회사 | 실린더 라이너용 회주철 및 이를 이용한 실린더 라이너의 제조방법 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2842804B1 (fr) * | 2002-07-29 | 2004-09-03 | Sanofi Synthelabo | Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique |
FR2861076B1 (fr) * | 2003-10-17 | 2006-01-06 | Sanofi Synthelabo | Derives de n-heterocyclymethylbenzamide, leur preparation et leur application en therapeutique |
WO2008065500A2 (en) * | 2006-11-30 | 2008-06-05 | Pfizer Products Inc. | Heteroaryl amides as type i glycine transport inhibitors |
TW200911808A (en) * | 2007-07-23 | 2009-03-16 | Astrazeneca Ab | Novel compounds |
-
2009
- 2009-04-14 FR FR0901809A patent/FR2944284A1/fr not_active Withdrawn
-
2010
- 2010-04-12 AR ARP100101220A patent/AR076276A1/es unknown
- 2010-04-13 JP JP2012505205A patent/JP2012523448A/ja not_active Withdrawn
- 2010-04-13 AU AU2010238409A patent/AU2010238409A1/en not_active Abandoned
- 2010-04-13 CA CA2758367A patent/CA2758367A1/fr not_active Abandoned
- 2010-04-13 BR BRPI1015484A patent/BRPI1015484A2/pt not_active Application Discontinuation
- 2010-04-13 EP EP10723665A patent/EP2419431A1/fr not_active Withdrawn
- 2010-04-13 TW TW099111503A patent/TW201041581A/zh unknown
- 2010-04-13 WO PCT/FR2010/050711 patent/WO2010119222A1/fr active Application Filing
- 2010-04-13 SG SG2011075017A patent/SG175222A1/en unknown
- 2010-04-13 KR KR1020117026894A patent/KR20120013378A/ko not_active Application Discontinuation
- 2010-04-13 MX MX2011010929A patent/MX2011010929A/es not_active Application Discontinuation
- 2010-04-14 UY UY0001032561A patent/UY32561A/es not_active Application Discontinuation
-
2011
- 2011-10-10 IL IL215673A patent/IL215673A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2010119222A1 (fr) | 2010-10-21 |
CA2758367A1 (fr) | 2010-10-21 |
UY32561A (es) | 2010-11-30 |
KR20120013378A (ko) | 2012-02-14 |
EP2419431A1 (fr) | 2012-02-22 |
SG175222A1 (en) | 2011-11-28 |
JP2012523448A (ja) | 2012-10-04 |
FR2944284A1 (fr) | 2010-10-15 |
MX2011010929A (es) | 2011-11-02 |
AR076276A1 (es) | 2011-06-01 |
TW201041581A (en) | 2010-12-01 |
BRPI1015484A2 (pt) | 2016-04-26 |
IL215673A0 (en) | 2012-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210387940A1 (en) | Methods of treating neurological and other disorders using enantiopure deuterium-enriched bupropion | |
CA2178161C (en) | Indole derivatives | |
CA2684149C (en) | Metabolites of (thio)carbamoyl-cyclohexane derivatives | |
SK102798A3 (en) | Azabicyclic esters of carbamic acids useful in therapy | |
HU214578B (hu) | Eljárás aril-acetamidok, valamint hatóanyagként ezen vegyületeket tartalmazó gyógyászati készítmények előállítására | |
NZ536015A (en) | N-[phenyl(piperidin-2-yl)methyl]benzamide derivatives, the preparation and their application in therapy | |
MXPA05000434A (es) | Derivados de hexano [3.1.0] azabiciclo 3,6-disustituido utiles como antagonistas de receptor muscarinico. | |
JPH0283375A (ja) | 2−置換ピペラジニル−2−(1,2−ベンズイソキサゾール−3−イル)酢酸誘導体 | |
US20120029027A1 (en) | N-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide derivatives, preparation thereof, and therapeutic use of same | |
AU2010238409A1 (en) | Derivatives of N-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, preparation thereof, and therapeutic use thereof | |
KATO et al. | Synthesis and structure-activity relationships of 4-amino-5-chloro-2-ethoxybenzamides with six-and seven-membered heteroalicycles as potential gastroprokinetic agents | |
SG173607A1 (en) | N-[(6-azabicyclo[3.2.1]oct-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof | |
US20120071536A1 (en) | N-[(2-azabicyclo[2.1.1]hex-1-yl)-aryl-methyl]-benzamide derivatives, preparation thereof, and therapeutic use thereof | |
US20030199500A1 (en) | Tetrahydrofuran derivatives and their use as nk-1 antagonists | |
KR20200031669A (ko) | 이소퀴놀리닐술포닐 유도체 및 이의 용도 | |
JPS6046109B2 (ja) | 1−(4−イソプロピルチオフェニル)−2−n−オクタノイルアミノプロパン誘導体およびその製造法 | |
MOR1E et al. | Heteroalicycles as Potential Gastroprokinetic Agents “_ | |
SG174434A1 (en) | Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics | |
JPH0283374A (ja) | アクリル酸誘導体 | |
FR2944283A1 (fr) | Derives de n-°(2-aza-bicyclo°2.1.1!hex-1-yl)-aryl-methyl!- heterobenzamide, leur preparation et leur application en therapeutique | |
FR2943056A1 (fr) | Derives de n-°2-aza-bicyclo°2.1.1!hex-1-yl)-aryl-methyl!- heterobenzamide, leur preparation et leur application en therapeutique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |